MiRNA-130a promotes inflammation to accelerate atherosclerosis via the regulation of proliferator-activated receptor γ (PPARγ) expression

MiRNA-130a promotes inflammation to accelerate atherosclerosis via the regulation of proliferator-activated receptor γ (PPARγ) expression

Saved in:

Bibliographic Details
Main Authors:	Fengtong Liu, Yali Liu, Yuqing Du, Youshan Li
Format:	Article
Language:	English
Published:	KARE Publishing 2021-09-01
Series:	Anatolian Journal of Cardiology
Online Access:	https://anatoljcardiol.com/jvi.aspx?un=AJC-56721&volume=25&issue=9
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Peroxisome Proliferator Activator Receptor (PPAR)-γ Ligand, but Not PPAR-α, Ameliorates Cyclophosphamide-Induced Oxidative Stress and Inflammation in Rat Liver
by: Azza A. K. El-Sheikh, et al.
Published: (2014-01-01)

New Target Genes for the Peroxisome Proliferator-Activated Receptor-γ (PPARγ) Antitumour Activity: Perspectives from the Insulin Receptor
by: Daniela P. Foti, et al.
Published: (2009-01-01)

Role of Peroxisome Proliferator-Activated Receptor-γ in Vascular Inflammation
by: Kousei Ohshima, et al.
Published: (2012-01-01)

Peroxisome proliferator‐activated receptor gamma (PPARγ) regulates lactase expression and activity in the gut
by: Mathurin Fumery, et al.
Published: (2017-09-01)

Nutraceuticals as Ligands of PPARγ
by: Meera Penumetcha, et al.
Published: (2012-01-01)

PPAR-γ in the Cardiovascular System
by: Sheng Zhong Duan, et al.
Published: (2008-01-01)

Dietary Modulation of Inflammation-Induced Colorectal Cancer through PPARγ
by: Ashlee B. Carter, et al.
Published: (2009-01-01)

Prostaglandins as PPARγ Modulators in Adipogenesis
by: Ko Fujimori
Published: (2012-01-01)

Effects of PPARγ Ligands on Leukemia
by: Yoko Tabe, et al.
Published: (2012-01-01)

PPARα/γ-Independent Effects of PPARα/γ Ligands on Cysteinyl Leukotriene Production in Mast Cells
by: Masamichi Yamashita
Published: (2008-01-01)

Synergistic Antiproliferative Effects of Combined γ-Tocotrienol and PPARγ Antagonist Treatment Are Mediated through PPARγ-Independent Mechanisms in Breast Cancer Cells
by: Abhita Malaviya, et al.
Published: (2014-01-01)

Shared Mechanisms in Pparγ1sv and Pparγ2 Expression in 3T3-L1 Cells: Studies on Epigenetic and Positive Feedback Regulation of Pparγ during Adipogenesis
by: Yasuhiro Takenaka, et al.
Published: (2024-01-01)

Redox Regulation of PPARγ in Polarized Macrophages
by: Verena Trümper, et al.
Published: (2020-01-01)

Role of PPARγ in the Differentiation and Function of Neurons
by: Rodrigo A. Quintanilla, et al.
Published: (2014-01-01)

PPARγ Agonists: Blood Pressure and Edema
by: Bonnie L. Blazer-Yost
Published: (2010-01-01)

Clinical Use of PPARγ Ligands in Cancer
by: Jennifer L. Hatton, et al.
Published: (2008-01-01)

LncRNA H19 promotes adipogenic differentiation disorder by sponging miR-130b-3p to upregulate PPARγ in steroid-induced osteonecrosis of the femoral head
by: Feifei Lin, et al.
Published: (2025-04-01)

Deciphering the Roles of Thiazolidinediones and PPARγ in Bladder Cancer
by: Melody Chiu, et al.
Published: (2017-01-01)

The Critical Role of PPARγ in Human Malignant Melanoma
by: Christian Freudlsperger, et al.
Published: (2008-01-01)

Current Understanding of the Role of PPARγ in Gastrointestinal Cancers
by: Bing Zou, et al.
Published: (2009-01-01)

Peroxisome Proliferator-Activated Receptor-γ Is Critical to Cardiac Fibrosis
by: Huang-Jun Liu, et al.
Published: (2016-01-01)

Microglia and Astrocyte Activation by Toll-Like Receptor Ligands: Modulation by PPAR-γ Agonists
by: Catherine Gurley, et al.
Published: (2008-01-01)

The Nuclear Hormone Receptor PPARγ as a Therapeutic Target in Major Diseases
by: Martina Victoria Schmidt, et al.
Published: (2010-01-01)

Nuclear Receptor Cofactors in PPARγ-Mediated Adipogenesis and Adipocyte Energy Metabolism
by: Emily Powell, et al.
Published: (2007-01-01)

The anti-diabetic PPARγ agonist Pioglitazone inhibits cell proliferation and induces metabolic reprogramming in prostate cancer
by: Emine Atas, et al.
Published: (2025-05-01)

PPAR-γ Ligand Inhibits Nasopharyngeal Carcinoma Cell Proliferation and Metastasis by Regulating E2F2
by: Ping-Li Yang, et al.
Published: (2019-01-01)

Bioinformatic Profiling of miRNAs in Coronary Artery Disease: Insights into Atherosclerosis and Inflammation
by: Ayesha Jabeen
Published: (2024-04-01)

Comparative Study of PPARγ Targets in Human Extravillous and Villous Cytotrophoblasts
by: Fulin Liu, et al.
Published: (2020-01-01)

Role of METTL16 in PPARγ methylation and osteogenic differentiation
by: Liangjie Lu, et al.
Published: (2025-04-01)

PPARγ Promotes Growth and Invasion of Thyroid Cancer Cells
by: William M. Wood, et al.
Published: (2011-01-01)

Signaling Mechanisms of Selective PPARγ Modulators in Alzheimer’s Disease
by: Manoj Govindarajulu, et al.
Published: (2018-01-01)

Synergistic Effects of PPARγ Ligands and Retinoids in Cancer Treatment
by: Masahito Shimizu, et al.
Published: (2008-01-01)

New Transcriptional Reporters to Quantify and Monitor PPARγ Activity
by: Séverine A. Degrelle, et al.
Published: (2017-01-01)

Role of Peroxisome Proliferator-Activated Receptor γ in Ocular Diseases
by: Su Zhang, et al.
Published: (2015-01-01)

Retinoid X receptor γ interacts with peroxisome proliferator-activated receptor-γ to promote browning during adipose tissue differentiation
by: Defei Chen, et al.
Published: (2025-12-01)

Peroxisome proliferator‐activated receptor gamma (PPARγ) is central to the initiation and propagation of human angiomyolipoma, suggesting its potential as a therapeutic target
by: Oren Pleniceanu, et al.
Published: (2017-03-01)

Effects of Glycyrrhizic Acid on Peroxisome Proliferator-Activated Receptor Gamma (PPARγ), Lipoprotein Lipase (LPL), Serum Lipid and HOMA-IR in Rats
by: Chia Yoke Yin, et al.
Published: (2010-01-01)

The Placenta Regulates Intrauterine Fetal Growth via Exosomal PPARγ
by: Xiaofang Luo, et al.
Published: (2025-04-01)

PPAR-γ agonist mitigates intestinal barrier dysfunction and inflammation induced by Clostridioides difficile SlpA in vitro
by: Maryam Noori, et al.
Published: (2024-12-01)

α-Bisabolol Mitigates Colon Inflammation by Stimulating Colon PPAR-γ Transcription Factor: In Vivo and In Vitro Study
by: Balaji Venkataraman, et al.
Published: (2022-01-01)